Treatment of Idiopathic Bronchiectasis With Aerosolized Recombinant Human DNase I
Open Access
- 1 May 1998
- journal article
- clinical trial
- Published by Elsevier BV in Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale
- Vol. 113 (5), 1329-1334
- https://doi.org/10.1378/chest.113.5.1329
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Imaging in bronchiectasisThe British Journal of Radiology, 1996
- Resolution of recurrent atelectasis in spinal cord injury patients with administration of recombinant human DNaseIntensive Care Medicine, 1996
- Recombinant human DNase in management of lobar atelectasis due to retained secretions.Thorax, 1995
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994
- Validation of a Vertical Visual Analogue Scale as a Measure of Clinical DyspneaRehabilitation Nursing Journal, 1989
- The Course and Prognosis of Different Forms of Chronic Airways Obstruction in a Sample from the General PopulationNew England Journal of Medicine, 1987
- Ambroxol for the Prevention of Chronic Bronchitis Exacerbations: Long-Term Multicenter TrialRespiration, 1987
- Chronic bronchial sepsis and progressive lung damage.BMJ, 1985
- Present outlook in bronchiectasis: clinical and social study and review of factors influencing prognosis.Thorax, 1981
- LIQUEFACTION OF VISCOUS PURULENT EXUDATES BY DEOXYRIBONUCLEASEThe Lancet, 1950